News
Initial Development Project Targets Predicting Flares in Patients Diagnosed with Atopic DermatitisFRIENDSWOOD, Texas, June 16 ...
Castle Biosciences and SciBase join forces to create a predictive test for atopic dermatitis flare-ups. Read more here.
Explore how health equity and policy shape outcomes, revealing disparities in kidney disease, atopic dermatitis, and cancer care for vulnerable populations.
EMA’s veterinary medicinal products committee recommends marketing authorization to Elanco’s Zenrelia to treat atopic dermatitis in dogs: Greenfield, Indiana Monday, June 16, ...
Ceramides aren’t just another moisturizer buzzword. From breakthrough lipid blends to ingestible rice-ceramide capsules, ...
BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S.
Discover how magnesium lotion offers 3 incredible benefits for sleep, muscle pain and skin health. Learn proper application tips and safety guidelines ...
INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.
Dog exposure was linked to significant changes in some genetic factors associated with risk for atopic eczema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results